· 1/13/2014
Williamson v. Albany Med. Ctr.
Citations
- 134 S. Ct. 941
- 187 L. Ed. 2d 809
- 82 U.S.L.W. 3406
- 571 U.S. 1144
- 2014 WL 102760
- 2014 U.S. LEXIS 213
How courts have described this case
Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.
- explaining that pharmaceutical companies have valid reasons for communicating with each other, and concluding that evidence of such communication, without more, is not enough to establish an unlawful conspiracy
- affirming exclusion of expert testimony where only other example of expert’s methodology was “unpublished, non-peer-reviewed working paper that [expert] co-authored during the course of this litigation”
- \[E]xpert testimony without ... a factual foundation cannot defeat a motion for summary judgment.\
- “[T]he argument that, [the generic manufacturer] would have incurred the risk of launching at risk or- that [it] would have won its ... suit against [the patent holder] depends on the theory that ... [the] patents were invalid or not infringed by a generic version.”
- ANDA filed and patent suits lasting years prior to settling
Source: CourtListener parenthetical corpus (CC0).
Sourced from CourtListener / Free Law Project (CC0).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.